Last reviewed · How we verify
NCT06266728: T30FA
T30 for Astigmatism in Digital Device Users
NA trial testing Total30 for Astigmatism Contact Lenses in Contact Lens Complication in 48 participants. Completed in 18 August 2024.
15 August 2024
Quick facts
| Lead sponsor | Southern College of Optometry |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 15 March 2024 |
| Primary completion | 15 August 2024 |
| Estimated completion | 18 August 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Total30 for Astigmatism Contact Lenses
Conditions studied
- Contact Lens Complication — all drugs for Contact Lens Complication →
- Astigmatism — all drugs for Astigmatism →
- Refractive Errors — all drugs for Refractive Errors →
Sponsor
Southern College of Optometry
Who can join
Adults 18 to 40, any sex, with Contact Lens Complication or Astigmatism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine if Total30 lenses for astigmatism can be successfully fit in participants who are heavy digital device users.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Performance of a Toric, Monthly, Soft Contact Lens in Digital Device Users.
Pucker AD, Franklin QX, Perkins AF, May K, et al · · 2025 · cited 2× · PMID 39867134 · DOI 10.2147/opto.s505701
Verify or expand the search:
- PubMed search for NCT06266728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contact Lens Complication
Currently open trials in the same condition.
- NCT06650306 — The Impact of Soft Contact Lenses on the Corneal Neuromediators and Optical Quality in High Myopia Prior to SMILE · recruiting
Other Southern College of Optometry trials
Trials by the same sponsor.
- NCT07267481 — Switching From Xiidra to TRYPTYR · Phase 4 · not yet recruiting
- NCT07267299 — Switching From Restasis to TRYPTYR · Phase 4 · not yet recruiting
- NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT07488208 — Comparison of Two Contact Lens Designs · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06266728 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Southern College of Optometry
- Last refreshed: 24 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06266728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing